Kristin Hodous | Senior Manager-Investor Relations |
Jeff Albers | Chief Executive Officer |
Kate Haviland | Chief Operating Officer |
Christy Rossi | Chief Commercial Officer |
Becker Hewes | Chief Medical Officer |
Mike Landsittel | Chief Financial Officer |
Fouad Namouni | President-Research & Development |
Marc Frahm | Cowen |
Dane Leone | Raymond James |
Brad Canino | Stifel |
Reni Benjamin | JMP Securities |
Mike Ulz | Morgan Stanley |
Eun Yang | Jefferies |
Joel Beatty | Baird |
Michael Schmidt | Guggenheim |
Peter Lawson | Barclays |
Good morning. My name is Lydia and I will be your conference operator today. At this time, I'd like to welcome everyone to the Blueprint Medicines’ Fourth Quarter and Full Year 2021 Financial Results Conference Call. [Operator Instructions] Thank you. Kristin Hodous you may begin your conference.